Samah Nassereddine MD

After an amazing night with @washingtonian, now heading to @ASH_hematology #ASH2023 So Thankful for all my colleagues and my patients. Thank you @GWCancer and @GWHospital

And it is a wrap #ASH2024

Strong work as usual Dr Issa..more hope for our AML patients

The first BTC trial to target AML MRD with combination of menin and BCL2 inhibition is now open! Huge team effort and more exciting trials for MRD to come. Goal is to better measure, understand and treat MRD

@malaksalharbi1 Wishing you great success with your boards and next steps in your career.

Studying for the oncology board is bittersweet .. On one hand, I feel excited about how much the field is advancing, and how much there is still to LEARN. On the other hand, I reflect on the BEAUTIFUL souls, families, emotions, and priceless moments I have shared along the way ..

@Charbel_matar1 shout out to this super star 🌟 fellow for presenting rare cases of HL arising in patients with CLL at @SocietyofHemOnc @GWCancer

Hematology rounds Very demure, very mindful @GWCancer

It was an incredible night launching our first MidAntlantic Fellow Blood 🩸 Club bringing institutions and fellows together. Thank you for everyone for making this a reality and our moderators and speakers. @DunleavyKieron, Dr Aarti shenoy and Dr J. Kanakri

Proud that at @GWCancer and @GWSMHS our Dean, our cancer center director and our chief of division are all woman. @AAMCtoday

So proud of Dr @Charbel_matar1 What a great representation to our cancer center @GWCancer

I am excited to present this oral presentation at @EHA_Hematology on the value of MRD in AML **as it is currently performed** from the @CIBMTR database @page_md @DrChrisHourigan library.ehaweb.org/eha/2024/eha20…

Another disease where BMT is starting to look irrelevant (too early to tell for sure) TRIANGLE: a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network - The Lancet thelancet.com/journals/lance…

@lab_rezvani @kchenken @mdaher @MDAndersonNews Bravo 🎉 @may_daher

Many congratulations @kchenken, Yujia Wang, Vakul Mohanty and @mdaher on this NIH-complement-ARIE prize. grateful for our collaboration! @MDAndersonNews

Thank you Dr. Gustavo Rivera and @OncLive for hosting a wonderful discussion on AML! And even better to see colleagues @CarrawayHetty @LaceyWilliamsMD @SamahNd Aarthi Shenoy at my old stomping ground @MedStarGUH

@SamahNd @Cancer_talks @GWCancer Excellent talk on AML at 2024 Hematology Update Symposium by Dr. Nassereddine

What an amazing way to end the #ASH23 celebrating Dr Rezvani Donnall award & so proud of my friends @may_daher @HindRafei for following the leads of an impressive leader in cellular therapy.

Hanging out with my DC contingent! @FirasElChaer @SamahNd #ASH2023

Outstanding presentations by ⁦@may_daher⁩ & ⁦@Byersdoc_BMT⁩ at the Immunometabolism as a tool to advance cell therapy session #ASH23 describing novel strategies to modulate and enhance the potency of immune effector cells for adoptive therapy ⁦@MDAndersonNews⁩

The best of #ash23 @KatieLaiMD_MPH @FirasElChaer

@KatieLaiMD_MPH @CART4AML Well done 🙏

Thank you @CART4AML for co-moderating an oral AML treatment session with me! #ASH2023

N-AVD vs BV-AVD in older patients with #Hodgkin #lymphoma. No words needed. To me, the new SoC #lymsm #ASH23